Treatment   |   Growth   |   Strategy

 LIVE ONLINE 20 May 2021

Bio Integrates Speakers 2021

ELIOT FORSTER

Chief Executive Officer

F-star

IAN MUIR

Chief Executive Officer

Porton Biopharma

MATTHEW DURDY

Chief Executive Officer

Cell and Gene Therapy Catapult

JANE DANCER

Independent Consultant

MARTINO PICARDO

Chairman

Discovery Park

SUZANNE DILLY

Chief Executive Officer

ValiRx PLC

JESÚS ZURDO

Global Head Bioproduction

Horizon Discovery

CHRISTIAN JONES

Chief Commercial Officer

Nanoform

KEVIN COX

Chair

ValiRx

IAN CAMPBELL

Chief Business Officer

LifeArc

JAMES FRY

Partner and Head of Life Sciences

Mills & Reeve

SHADI FARHANGRAZI

Chief Executive Officer

S. M. Discovery Group

KATHRYN SIMPSON

Business Consultant

Kathryn Simpson Consulting

JONATHAN APPLEBY

Chief Scientific Officer

Cell and Gene Therapy Catapult

PATRICK DRISCOLL

Chief Financial Officer

CN Bio Innovations

TIM BREARS

Chief Executive Officer

Evonetix

CLARE TERLOUW

Head of Ventures

LifeArc

JOHN POTTAGE

Former Senior Vice President, Chief Scientific and Medical Officer

ViiV Healthcare

MEL WALKER

Managing Director

BioPharma Futures

TOBY REID

Chief Executive Officer

BioCity Group

WILL BROOKS

Investment Director

Downing

EUAN CAMERON

Chief Executive Officer & Founder

COHESION Medical

ZAHID MONEER

Managing Director Healthcare Investment Banking

BNP Paribas

VICKY STEADMAN

Senior Director, Business Development

Sai Life Sciences

PRIYA MANDE

Chief Operating Officer

PsiOxus Therapeutics

AJAY MISTRY

Co-Founder & Chief Executive Officer

Oppilotech

EMMANUEL LIGNER

President and Chief Executive Officer

Cytiva

KATH MACKAY

Managing Director

Bruntwood SciTech – Alderley Park

MAIREADH PEDERSEN

Chief Executive Officer

QuayPharma

DAVID PORTER

Founding Partner

Apposite Capital

MARTIN-IMMANUEL BITTER

Chief Executive Officer

Arctoris

REBECCA TODD

Investment Director

Longwall Venture Partners

NATALIA NOVAC

Senior Director, Emerging Technology & Innovation, Corporate Business Development

Eli Lilly

RICHARD WEAVER

Senior Vice President – Pre-Clinical Development

Sygnature Discovery

BRUCE CLARK

Independent Consultant

CLAIRE BROWN

Investment Director

BioCity

DOUG DANISON

Head of Europe

Bluebird Bio

CAROLE LONGSON

Independent Senior Adviser, Life Science Policy, HTA and Market Access and Vice Chair

Medicines Discovery Catapult

TOM MANDER

Chief Operating Officer

Domainex

RICHARD WILLIAMS

SVP CMC and Development

Crescendo Biologics

TIM LUKER

Vice President Emerging Technology and Innovation

ELI LILLY

JAMES ZHANG

Co-Founder and Chief Executive Officer

Phoenix DX

MIKE FRODSHAM

Chief Technical Officer

QuayPharma

NATHALIE HUTHER

Senior Director of Business Development, Europe

Arcinova – A Quotient Sciences business

PETER LYFORD

Business Development Director

Porton Pharma Solutions

ROISIN NICAMHLAOIBH

Head of Partnerships and Business Development

Rosalind Franklin Institute

PAUL STOTT

Chief Executive Officer

Seda Pharmaceutical Development Services

ALEX HAMILTON

Partner

Syncona Investment Management

JOANNA GOULD

Chief Executive Officer and Co-Founder

VisusNano

JENNY LAIRD

Vice President, Search & Evaluation Pain & Neurodegeneration

Eli Lilly

EDDIE BLAIR

Chairman

Virokine Therapeutics

KARL KEEGAN

Chief Executive Officer

Hox Therapeutics Ltd

STEPHEN TOOKER

Vice President, Commercial Packaging – Europe

PCI Pharma Services

JOE DE SOUSA

Senior Leader, Non-Exec Director and Independent Consultant

Melhor Consulting

JASON MELLAD

Chief Executive Officer

Start Codon

STEVE McCONCHIE

Chief Executive Officer

Aptus Clinical

MATTHEW DUCHARS

Chief Executive Officer

VMIC UK

JILL RECKLESS

Chief Executive Officer

RxCelerate

ADRIAN HILL

Head of HealthTec Development

UKRI – STFC Harwell Campus

DAVID ATKINS

Chief Executive Officer

Congenica

AMIT SHAH

Biotech Venture Capital Investor

S.R. One Ltd

HENRI LOUW

HR Director

AbbVie

CATHERINE PICKERING

Chief Executive Officer and Co-founder

iOnctura SA

JOHN COLEMAN

Head of Quality and Business Development

Your Special Delivery Service

PATRICIA FURLONG

Founding President and Chief Executive Officer

Parent Project Muscular Dystrophy (PPMD)

FLIC GABBAY

Managing Partner

tranScrip

EMMA PALMER FOSTER

Healthcare Consultant, Corporate & Financial Strategy | IR | Communications

EJ Palmer Consulting

TIM HAINES

Chairman and Managing Partner

Abingworth LLP

HEATHER FAIRHEAD

Founder and Chief Executive Officer

Phico Therapeutics

WILLS HUGHES-WILSON

Chief Patient Access & Commercial Planning

Mereo Biopharma

JASON FOSTER

Chief Executive Officer and Executive Director

Ori Biotech

JOLYON MARTIN

Founder and Business Development

PetMedix

LUCY FOLEY

Director of Biologics

CPI

GRAHAM BOND

Managing Partner

RSM UK Audit LLP

SONIA HOUGHTON

Chief Executive Officer & Co-Founder

Cryoniss

FRAN CRAWFORD

Chief Executive Officer

Somaserve

DEBORA LUCARELLI

Chief Executive Officer

Enhanc3D Genomics

GREG BROOKE

Senior Lecturer in Molecular and Cellular Biology

University of Essex

Valued silver sponsors 

Treatment   |   Growth   |   Strategy

 LIVE ONLINE 20 May 2021